| Financial Year |
March 31 2023 |
| Monetary Funds |
2,550,924,952.76 |
| Held-for-trading Financial Assets |
544,220,114.30 |
| Notes Receivable |
-- |
| Accounts Receivable |
54,037,023.99 |
| Advances to Suppliers |
39,307,743.64 |
| Other Receivables |
82,148,785.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
412,881,320.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
33,237,274.90 |
| Total Current Assets |
3,716,757,215.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
510,014,947.72 |
| Under-construction Projects |
1,754,082.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,472,637.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
34,045,634.21 |
| Deferred Income Tax Assets |
88,486,597.89 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
780,888,883.13 |
| Total Assets |
4,497,646,098.57 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
100,000,000.00 |
| Accounts Payable |
48,111,273.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,744,046.96 |
| Taxes Payable |
96,103,822.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
103,277,269.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
83,798,554.64 |
| Other Current Liabilities |
107,146,600.00 |
| Sub-Total of Current Liabilities |
713,294,326.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,570,170.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
44,973,292.94 |
| Total Liabilities |
758,267,619.12 |
| Paid-In Capital(Or Share Stock) |
481,077,600.00 |
| Capital Surplus |
1,482,789,131.16 |
| Surplus Reserve |
240,600,000.00 |
| LESS:Treasury Stock |
151,119,948.00 |
| Undistributed Profits |
1,682,507,954.28 |
| Minority Stockholder's Interest |
1,515,019.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,737,863,459.73 |
| Owner's Equity（Stockholder's Equity） |
3,739,378,479.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,497,646,098.57 |
